Warangkana Keeratichananont1, Chokchai Thanadetsuntorn2, Suriya Keeratichananont3. 1. Assistant Professor, Division of Respiratory and Respiratory Critical Care Medicine, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand tik25572014@gmail.com. 2. Division of Respiratory and Respiratory Critical Care Medicine, Department of Medicine, Faculty of Medicine, Songklanakarind Hospital, Prince of Songkla University, Songkhla, Thailand. 3. Department of Medicine, Bangkok Hospital Hatyai, Songkhla,Thailand.
Abstract
OBJECTIVES: The objective of this study was to determine the performance of preoperative 6-minute walk test (6MWT) for predicting postoperative pulmonary complications (PPC) in high risk patients undergoing elective surgery under general anesthesia. METHODS: A prospective cohort study was conducted in patients scheduled to undergo elective thoracic or nonthoracic surgery and indicated for preoperative pulmonary evaluation in Songklanagarind Hospital, Songkhla, Thailand. Preoperative spirometry, 6MWT were done and 30-day PPC were recorded. The multiple regression analysis and receiver operating characteristic (ROC) curves were used to analyze the variables and to compare the performance of 6MWT and spirometry tests. RESULTS: A total of 78 participants were recruited into the study. 6MWT was done completely in all cases without any complications. Among these tests, 14 cases (17.9%) had contraindications to spirometry and two cases were unable to achieve the criteria for acceptable efforts. PPC developed in 17 cases (21%) with a high mortality (17.7%). A multiple regression analysis showed elderly, poor general health status, smoking history, low level of the mean value of forced expiratory volume in 1 second (FEV1) % predicted (by spirometry) and shorter 6-minute walk distance (6MWD) were the independent factors associated with PPC. Patients developing PPC had a significantly lower preoperative 6MWD compared with patients without PPC (256.0 ± 48.0 versus 440.0 ± 117.1 meters, p < 0.001). 6MWD of ⩽325 meters was a threshold for predicting PPC with 77% sensitivity and 100% specificity, and had a good predictive value for PPC similar to that for the FEV1 %. CONCLUSIONS: Preoperative 6MWT is a very useful alternative test for predicting PPC in high risk patients scheduled to undergo surgery under GA.
OBJECTIVES: The objective of this study was to determine the performance of preoperative 6-minute walk test (6MWT) for predicting postoperative pulmonary complications (PPC) in high risk patients undergoing elective surgery under general anesthesia. METHODS: A prospective cohort study was conducted in patients scheduled to undergo elective thoracic or nonthoracic surgery and indicated for preoperative pulmonary evaluation in Songklanagarind Hospital, Songkhla, Thailand. Preoperative spirometry, 6MWT were done and 30-day PPC were recorded. The multiple regression analysis and receiver operating characteristic (ROC) curves were used to analyze the variables and to compare the performance of 6MWT and spirometry tests. RESULTS: A total of 78 participants were recruited into the study. 6MWT was done completely in all cases without any complications. Among these tests, 14 cases (17.9%) had contraindications to spirometry and two cases were unable to achieve the criteria for acceptable efforts. PPC developed in 17 cases (21%) with a high mortality (17.7%). A multiple regression analysis showed elderly, poor general health status, smoking history, low level of the mean value of forced expiratory volume in 1 second (FEV1) % predicted (by spirometry) and shorter 6-minute walk distance (6MWD) were the independent factors associated with PPC. Patients developing PPC had a significantly lower preoperative 6MWD compared with patients without PPC (256.0 ± 48.0 versus 440.0 ± 117.1 meters, p < 0.001). 6MWD of ⩽325 meters was a threshold for predicting PPC with 77% sensitivity and 100% specificity, and had a good predictive value for PPC similar to that for the FEV1 %. CONCLUSIONS: Preoperative 6MWT is a very useful alternative test for predicting PPC in high risk patients scheduled to undergo surgery under GA.
Authors: Steven D Nathan; Roland M du Bois; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Alex Kartashov; Paul W Noble; Steven A Sahn; Dominique Valeyre; Derek Weycker; Talmadge E King Journal: Respir Med Date: 2015-04-24 Impact factor: 3.415
Authors: Peng-Ming Yu; Yu-Qiang Wang; Ze-Ruxing Luo; Raymond C C Tsang; Oystein Tronstad; Jun Shi; Ying-Qiang Guo; Alice Y M Jones Journal: Front Cardiovasc Med Date: 2022-05-19
Authors: An Ngo-Huang; Nathan H Parker; Eduardo Bruera; Rebecca E Lee; Richard Simpson; Daniel P O'Connor; Maria Q B Petzel; Rhodora C Fontillas; Keri Schadler; Lianchun Xiao; Xuemei Wang; David Fogelman; Sunil K Sahai; Jeffrey E Lee; Karen Basen-Engquist; Matthew H G Katz Journal: Integr Cancer Ther Date: 2019 Jan-Dec Impact factor: 3.279
Authors: Roy A Hilzenrat; Shaun A Deen; John Yee; Kyle A Grant; Ahmad S Ashrafi; Shaun Coughlin; Anna L McGuire Journal: Curr Oncol Date: 2021-02-18 Impact factor: 3.677